Ocular Therapeutix(TM) to Participate in December Investor and Scientific Conferences
Piper Sandler 36th Annual Healthcare Conference Fireside Chat Date: Tuesday, December 3rd, 2024 Fireside Chat Time: 1:30 PM ET Presenter: Pravin U. Dugel, MD, Executive Chairman, President and CEO ...
Too Old to Operate4m
Analysis of Lichen Planus Prevalence and Treatment Approaches
The following is a summary of “Prevalence and Treatment Patterns of Lichen Planus,” published in the November 2024 issue of ...
Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences
Piper Sandler 36th Annual Healthcare Conference Fireside Chat Date: Tuesday, December 3rd, 2024 Fireside Chat Time: 1:30 PM ET Presenter: Pravin U. Dugel, MD, Executive Chairman, President and CEO ...
Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
Bempedoic acid has a novel mechanism of action that inhibits a cholesterol synthesis pathway by acting on ATP (adenosine triphosphate) citrate lyase, a citrate-degrading enzyme in the liver. Bempedoic ...